Matthias Leisegang

ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 12

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

Blood

Nature biotechnology

EMBO molecular medicine

Charité Universitätsmedizin Berlin Campus Berlin Buch

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Charité Universitätsmedizin Berlin Campus Berlin Buch Dec 01 2017

Germany

Juniorprofessor :: Institute of Immunology

Publications

Steven P Wolf, Vasiliki Anastasopoulou, Kimberley Drousch, Markus I Diehl, Boris Engels, Poh Yin Yew, Kazuma Kiyotani, Yusuke Nakamura, Karin Schreiber, Hans Schreiber, Matthias Leisegang
One CD4+TCR and One CD8+TCR Targeting Autochthonous Neoantigens Are Essential and Sufficient for Tumor Eradication. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (8) (2024)
Steven P Wolf, Matthias Leisegang, Madeline Steiner, Veronika Wallace, Kazuma Kiyotani, Yifei Hu, Leonie Rosenberger, Jun Huang, Karin Schreiber, Yusuke Nakamura, Andrea Schietinger, Hans Schreiber
CD4 + T cells with convergent TCR recombination reprogram stroma and halt tumor progression in adoptive therapy. Science immunology 9 (99) (2024)
Amin Ben Hamza, Carlotta Welters, Serena Stadler, Monika Brüggemann, Kerstin Dietze, Olaf Brauns, Tim Henrik Brümmendorf, Thomas H Winkler, Lars Bullinger, Thomas Blankenstein, Leonie Rosenberger, Matthias Leisegang, Thomas Kammertöns, Wolfgang Herr, Andreas Moosmann, Julian Strobel, Holger Hackstein, Klaus Dornmair, Fabian Beier, Leo Hansmann
Virus-reactive T cells expanded in aplastic anemia eliminate hematopoietic progenitor cells by molecular mimicry. Blood (2024)
Steven P Wolf, Vasiliki Anastasopoulou, Kimberley Drousch, Markus I Diehl, Boris Engels, Poh Yin Yew, Kazuma Kiyotani, Yusuke Nakamura, Karin Schreiber, Hans Schreiber, Matthias Leisegang
One CD4+TCR and one CD8+TCR targeting autochthonous neoantigens are essential and sufficient for tumor eradication. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Amin Ben Hamza, Carlotta Welters, Serena Stadler, Monika Brüggemann, Kerstin Dietze, Olaf Brauns, Tim Henrik Brümmendorf, Thomas Winkler, Lars Bullinger, Thomas Blankenstein, Leonie Rosenberger, Matthias Leisegang, Thomas Kammertöns, Wolfgang Herr, Andreas Moosmann, Julian Strobel, Holger Hackstein, Klaus Dornmair, Fabian Beier, Leo Hansmann
Virus-reactive T cells expanded in aplastic anemia eliminate hematopoietic progenitor cells by molecular mimicry. Blood 143 (14) (2024)
Steven P Wolf, Vasiliki Anastasopoulou, Kimberley Drousch, Markus I Diehl, Boris Engels, Poh Yin Yew, Kazuma Kiyotani, Yusuke Nakamura, Karin Schreiber, Hans Schreiber, Matthias Leisegang
One CD4+TCR and One CD8+TCR Targeting Autochthonous Neoantigens Are Essential and Sufficient for Tumor Eradication. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (8) (2024)
Amin Ben Hamza, Carlotta Welters, Serena Stadler, Monika Brüggemann, Kerstin Dietze, Olaf Brauns, Tim Henrik Brümmendorf, Thomas H Winkler, Lars Bullinger, Thomas Blankenstein, Leonie Rosenberger, Matthias Leisegang, Thomas Kammertöns, Wolfgang Herr, Andreas Moosmann, Julian Strobel, Holger Hackstein, Klaus Dornmair, Fabian Beier, Leo Hansmann
Virus-reactive T cells expanded in aplastic anemia eliminate hematopoietic progenitor cells by molecular mimicry. Blood (2024)
Steven P Wolf, Vasiliki Anastasopoulou, Kimberley Drousch, Markus I Diehl, Boris Engels, Poh Yin Yew, Kazuma Kiyotani, Yusuke Nakamura, Karin Schreiber, Hans Schreiber, Matthias Leisegang
One CD4+TCR and One CD8+TCR Targeting Autochthonous Neoantigens Are Essential and Sufficient for Tumor Eradication. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (8) (2024)
Steven P Wolf, Vasiliki Anastasopoulou, Kimberley Drousch, Markus I Diehl, Boris Engels, Poh Yin Yew, Kazuma Kiyotani, Yusuke Nakamura, Karin Schreiber, Hans Schreiber, Matthias Leisegang
One CD4+TCR and One CD8+TCR Targeting Autochthonous Neoantigens Are Essential and Sufficient for Tumor Eradication. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (8) (2024)
Zsofia Foldvari, Cathrine Knetter, Weiwen Yang, Thea Johanne Gjerdingen, Ravi Chand Bollineni, Trung The Tran, Fridtjof Lund-Johansen, Arne Kolstad, Kimberley Drousch, Robert Klopfleisch, Matthias Leisegang, Johanna Olweus
A systematic safety pipeline for selection of T-cell receptors to enter clinical use. NPJ vaccines 8 (1) (2023)
Muhammad Ali, Eirini Giannakopoulou, Yingqian Li, Madeleine Lehander, Stina Virding Culleton, Weiwen Yang, Cathrine Knetter, Mete Can Odabasi, Ravi Chand Bollineni, Xinbo Yang, Zsofia Foldvari, Maxi-Lu Böschen, Eli Taraldsrud, Erlend Strønen, Mireille Toebes, Amy Hillen, Stefania Mazzi, Arnoud H de Ru, George M C Janssen, Arne Kolstad, Geir Erland Tjønnfjord, Benedicte A Lie, Marieke Griffioen, Sören Lehmann, Liv Toril Osnes, Jochen Buechner, K Christopher Garcia, Ton N M Schumacher, Peter A van Veelen, Matthias Leisegang, Sten Eirik W Jacobsen, Petter S Woll, Johanna Olweus
T cells targeted to TdT kill leukemic lymphoblasts while sparing normal lymphocytes. Nature biotechnology (2021)
Thomas Kammertoens, Josephine Kemna, Matthias Leisegang
"Designer cytokines" targeting the tumor vasculature-think global and act local. EMBO molecular medicine 12 (2) (2020)

Matthias Leisegang.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Matthias Leisegang